North American Pharmaceutical Payer & Health Technology Assessment Summit, May 16-17, 2011, Washington DC

This meeting will provide an ideal opportunity for "payers" and other decision makers from both public and private organisations, to benchmark with peers internationally. Attendees will be able to understand and develop best practice approaches to such vital and common challenges, with the ultimate goal of encouraging innovation and improving patient access to novel and powerful medications.



Why Attend?


Pharmaceutical industry executives & consultants
Find out what payers want and integrate their needs earlier into the clinical trial process, for stronger evidence and faster market access.
Spend 2 days networking with senior decision makers from payer organisations, build relationships and strengthen dialogue (including an exclusive networking dinner). Many payers will be in the audience, not just on the speaker list.
Understand the mentality of payers, who are making difficult decisions to control the costs of expensive drugs, with limited evidence, tight budgets and pressure to improve health outcomes.
Discover how drug technologies will be assessed in the future by various stakeholders, how reimbursement decisions will be made and how this will effect your present and future market access.
Payers/HTAs/Departments of Health
Understand the latest developments and methodologies to improve HTA to enable smarter, faster decision making on innovative drugs.
Find out other ways to cut costs, such as improving prescriber guidance and incentives, enhancing patient adherence to avoid wastage and raise outcomes.
Work out how to improve communication with the pharma industry and improve pre and post approval scientific guidance, to obtain the most-relevant, accurate data that you need to help you make the right decisions.
Have your say! Be part of a personal, interactive environment and the chance to help lead the debate on issues crucial to the future healthcare and patient access.
Gain an insight into the future of healthcare and regulatory harmonization at the local, national, regional and global level, and discover what could be the models of the future.

Who will benefit?


PRIMARILY: Senior representatives from public & private health plans & insurers (i.e. heads of pharmacy strategy), payers, health technology assessors, hospital financial management, government & health department officials, health maintenance and managed care organizations.


STAKEHOLDERS: Regulatory agencies, PBMs, key-opinion-leaders, independent health economists and academics, physicians, patient groups and other key stakeholders.


INDUSTRY: A strictly limited number of senior pharmaceutical industry representatives.



Conference Dates: May 16-17th, 2011

Venue: Washington DC



Agenda request



Disclaimer


Important: NextLevel Pharma is an independent events organiser for the life sciences community, who is dedicated to providing neutral and objective benchmarking and networking opportunities to those committed to advancing healthcare and patient access to innovative medications. We are not sponsored by the pharmaceutical industry and do not receive any corporate level funding from industry.


Booking Information contact:
Erika Vavrovicova

Tel: +421 232 660 382

Fax: +421 2 3301 0331

Email: erikanextlevelpharma

Visit: nextlevelpharma

We Recommend:


•   Purchase Famvir Online
•   Purchase Anti Flu Face Mask Online
•   Purchase Anti-Bacterial Face Mask
•   Buy Anti Flu Face Mask Online No Prescription
•   Buy Cheap Retrovir